Wake Forest Medicare Agent Offers Unrivaled Medicare Plan Comparison Tools For People New to Medicare
Neuse Consulting Group Unveils Advanced Medicare Plan Comparison Tools for New Beneficiaries in Wake Forest, NC
Wake Forest, NC – Navigating the complexities of Medicare can be overwhelming for newcomers. Recognizing this challenge, Neuse Consulting Group, a top-rated Medicare insurance agency based in Wake Forest, North Carolina, is proud to announce the launch of their advanced Medicare plan comparison tools. These innovative resources are designed to simplify the decision-making process, empowering individuals new to Medicare to make informed choices about their healthcare coverage.
Empowering Beneficiaries with Comprehensive Comparison Tools
Neuse Consulting Group's state-of-the-art comparison tools provide users with clear, side-by-side analyses of various Medicare options, including:
Medigap Plans: Supplemental insurance that covers costs not included in Original Medicare Parts A and B.
Medicare Advantage Plans: Alternative plans to Original Medicare, typically structured as HMO or PPO plans with network providers.
Prescription Drug Plans: Plans designed to assist with the cost of prescription medications.
These tools are tailored to help beneficiaries assess their coverage needs, budget constraints, and preferred healthcare providers, ensuring they make informed decisions about their healthcare coverage.
Personalized Consultations for In-Depth Guidance
Beyond the digital tools, Neuse Consulting Group offers personalized consultations to address individual concerns and provide expert guidance. Understanding that each beneficiary's situation is unique, their experienced agents are available for:
Over-the-Phone Quotes and Consultations: Offering convenience and immediate insights since 2020.
Video Call Consultations: For those who prefer face-to-face interactions without leaving their homes.
In-Person Meetings: Available for clients who value direct personal engagement.
This flexible approach ensures that clients receive the support they need in the manner most comfortable for them.
A Commitment to Client Satisfaction
Neuse Consulting Group's dedication to client satisfaction is evident in their impressive track record:
12,000+ Satisfied Customers Last Year: Reflecting their commitment to excellence and personalized service.
40+ Carrier Relationships: Providing a broad spectrum of options to meet diverse client needs.
24% Average Savings: Demonstrating their ability to find cost-effective solutions for their clients.
100% Guaranteed Results: Ensuring clients receive the best possible outcomes for their healthcare coverage.
Educational Resources to Navigate Medicare
To further assist those new to Medicare, Neuse Consulting Group offers a wealth of educational resources, including:
Medicare 101: A comprehensive guide to understanding the basics of Medicare and prescription hurdles.
Retirement Roadblocks 101: Insights into avoiding the four major retirement roadblocks, empowering individuals to take charge of their retirement journey.
These resources are designed to empower beneficiaries with the knowledge they need to make informed decisions about their healthcare and financial future.
About Neuse Consulting Group
Located in Wake Forest, NC, Neuse Consulting Group is a top-rated North Carolina Medicare insurance agency. They specialize in guiding clients through Medicare, health, life, and annuity options, ensuring personalized solutions that meet individual needs. Their mission is to alleviate the stresses of insurance decisions, making the process straightforward and tailored to each client.
Wake Forest, NC
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 hours ago
- Yahoo
New Medicare program offers much-needed relief for caregivers of dementia patients
A new Medicare program covering services for at-home nursing care for dementia patients has received the green light to expand nationwide following a yearlong pilot program. It's a first for Medicare, spotlighting the needs of the more than 11 million unpaid family caregivers of people with dementia. The voluntary program, called GUIDE (Guiding an Improved Dementia Experience), initially started with a Biden administration executive order to test a new model focused on dementia care that pays for some family caregiver support. 'For unpaid caregivers, who face not only difficult care responsibilities and decisions, but also serious financial consequences with few opportunities for help with training or short-term respite breaks, the program is a significant start,' Cindy Hounsell, founder and president of the Women's Institute for a Secure Retirement (WISER), told Yahoo Finance. Approximately two-thirds of dementia caregivers are women, according to Centers for Disease Control and Prevention (CDC) data. The GUIDE program is now offered in 45 states — all but Alaska, the Dakotas, Kansas, and Mississippi — and includes roughly 330 Medicare-participating providers, including large academic medical centers, hospital health systems, small group practices, community-based organizations, and hospice agencies. The initiative has been approved for an eight-year run. More than 6.9 million people in the US are living with dementia stemming from a range of diseases such as Alzheimer's and Parkinson's, according to a 2024 report from the National Institutes of Health. As the population in the US ages, cases are expected to jump to nearly 14 million by 2060. Most people with dementia in the US live at home. About 8 in 10 adults with dementia live in their homes with spouses or other family members, according to the CDC. How it works Eligible patients must be enrolled in Medicaid or original Medicare — not Medicare Advantage. To qualify, patients must have a diagnosis of moderate to severe dementia and not live in an assisted care facility, nursing home, or be receiving hospice care. They must also be patients of a participating provider. The program pays up to $2,500 each year per beneficiary for respite benefits, which cover the cost for in-home caregivers, overnight care, or adult day care. Last year, the national median pay for home health and personal care aides was $16.78 per hour. Translation: the program could cover 148 hours of in-home care, giving family caregivers a chance to take a break. The program doesn't provide Medicare patients with the funds to directly pay these caregivers who step in to lend a hand. It provides Medicare payments to those provider organizations that, in turn, cover the caregiver's pay. In addition, the program includes round-the-clock access to a support line to connect directly to a licensed nurse who can answer questions. This is particularly useful in case of emergencies and can defray a hospital visit in some cases, Hounsell said. Many family caregivers aren't trained to handle medical or nursing tasks such as managing catheters, performing injections, or monitoring vital signs. To address this gap, the new Medicare initiative provides access to caregiver training and education. Sign up for the Mind Your Money weekly newsletter By subscribing, you are agreeing to Yahoo's Terms and Privacy Policy Savings are two-fold Ideally, the program will cut costs for Medicare in fewer emergency room visits and short-term hospital stays for those with dementia. For families of those with dementia, the end goal is to help those patients stay at home longer and avoid the high cost of assisted care or nursing homes, which can be a massive drain on a family's finances. It often comes as a shock to people that Medicare doesn't cover the cost of long-term care facilities, which can quickly top tens of thousands of dollars. An apartment in an assisted-living facility had an average rate of $74,148 a year in 2024, according to the National Investment Center for Seniors Housing & Care — and costs go up as residents age and need more care. Units for dementia patients can run more than $94,000. 'Alternative payment models like this are critical to helping individuals remain in the setting of their choice,' said Mollie Gurian, vice president for policy and government affairs at LeadingAge, an association of nonprofit providers of aging services. 'These participating providers understand the complexity of caring for older adults with dementia and recognize that family and friends are essential members of the care team.' Kerry Hannon is a Senior Columnist at Yahoo Finance. She is a career and retirement strategist and the author of 14 books, including the forthcoming "Retirement Bites: A Gen X Guide to Securing Your Financial Future," "In Control at 50+: How to Succeed in the New World of Work," and "Never Too Old to Get Rich." Follow her on Bluesky. Sign up for the Mind Your Money newsletter Sign in to access your portfolio
Health Line
12 hours ago
- Health Line
Does Medicare Cover Saxenda for weight loss?
Saxenda (liraglutide) is a GLP-1 agonist injection pen medication used to support long-term weight loss in adults with obesity, adults with overweight and weight-related health issues, and certain children. Doctors usually prescribe it as part of a comprehensive weight management plan that includes dietary changes and regular exercise. Does Medicare cover Saxenda for older adults? Medicare drug plans don't cover Saxenda because Medicare doesn't cover GLP-1 agonists when prescribed for weight loss. Medicare may cover some GLP-1 agonists when prescribed to treat another health condition, like diabetes. However, the Food and Drug Administration (FDA) only approves prescribing Saxenda for weight loss, meaning Medicare doesn't cover the drug. How much is a 30-day supply of Saxenda? Without insurance coverage, Saxenda isn't cheap. One injection package costs around $1,400. You may be able to afford Saxenda via the manufacturer's savings program, which reduces the price to $25 per box. Contact the manufacturer to verify your eligibility. According to the manufacturer, this drug's availability is currently limited due to significant demand. So, you may, in some cases, have difficulty filling your prescription. Is there a weight loss drug covered by Medicare? The government set a goal to broaden Medicare and Medicaid coverage of GLP-1 drugs for weight loss alone by 2026. But the current administration abandoned the initiative. However, if you have diabetes, you can get alternative GLP-1 agonists covered through Medicare if prescribed to treat your disease rather than for weight loss. These include Mounjaro (tirzepatide) and Ozempic (semaglutide). If you have obesity, you can get Wegovy (semaglutide) if you're at a high risk of heart attack or stroke. How do I know if my insurance covers an alternative to Saxenda? If you're eligible for coverage of one of the aforementioned GLP-1 agonists based on your health, your Medicare drug plan should generally cover some of these drugs. The GLP-1 drugs you can get through Medicare Part D or a Medicare Advantage prescription drug (MAPD) plan, and how much you may pay out of pocket after coverage, will depend on your specific plan. The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
Yahoo
12 hours ago
- Yahoo
Hims & Hers Fuels Growth via Market Expansion and New Care Verticals
The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, is building its market opportunity around democratizing access to personalized healthcare, particularly in areas that have historically been underserved. By the second quarter of 2025, the platform had grown to 2.4 million subscribers supported by nearly 1,500 licensed providers. Its weight loss specialty, anchored in GLP-1 treatments, highlights the strength of its model, delivering retention rates above industry averages thanks to continuous provider engagement and integrated digital support. Hims & Hers is preparing to expand further into hormonal health with offerings that target menopause and low testosterone, conditions representing a large U.S. market opportunity. Integrated lab testing and a broader shift toward longevity and preventive care are expected to increase patient lifetime value while positioning it as more than just a treatment provider. Instead, HIMS aims to play a role in long-term health optimization and proactive care. International expansion is another powerful growth driver. The acquisition of ZAVA extends Hims & Hers' footprint across the U.K., Germany, France and Ireland, granting immediate access to more than 1.3 million existing patients and strengthening its position as a global digital health leader. Planned entry into Canada in 2026, aligned with the introduction of generic semaglutide, will likely make weight loss treatments significantly more affordable and accessible for a population where obesity rates remain high. Together, vertical integration, entry into new therapeutic categories and global expansion underscore Hims & Hers' capacity to sustain momentum and capture long-term market share. LFMD & AMWL's Market Opportunities and Growth Drivers LifeMD, Inc.'s LFMD market opportunity centers on scaling a vertically integrated, subscription telehealth platform across primary care and lifestyle conditions. LFMD is adding commercial insurance and Medicare coverage pathways, expanding reach and conversion. Growth drivers include LifeMD's owned pharmacy with planned non-sterile compounding, enabling cost and fulfillment control, a GLP-1 weight-management program with tens of thousands of subscribers and B2B partnerships for at-home labs and remote monitoring (Ash Wellness, Withings) that deepen personalization and retention. LifeMD's telehealth revenues grew 29.7% year over year in second-quarter 2025, underscoring sustained demand. American Well Corporation's AMWL, popularly known as Amwell, market opportunity is tied to enterprise, payer and government modernization of care. Amwell's platform powers the Military Health System's virtual visits worldwide, replacing MHS Video Connect. This change has nearly tripled virtual visit volumes. A one-year extension sustains this presence across about 9.6 million beneficiaries. Amwell's growth drivers include increasing subscription software mix, new wins like Florida Blue and AI-enabled efficiency as it targets positive operating cash flow in 2026. Amwell continues positioning as a unified, tech-enabled care platform for large systems. HIMS' Price Performance, Valuation and Estimates Shares of Hims & Hers have gained 86.5% year to date, outperforming the industry's growth of 23.5%. Image Source: Zacks Investment Research HIMS' forward 12-month P/S of 3.8X is lower than the industry's average of 5.8X, but is higher than its three-year median of 2.4X. It carries a Value Score of D. Image Source: Zacks Investment Research The Zacks Consensus Estimate for HIMS' 2025 earnings per share suggests a 137% improvement from 2024. Image Source: Zacks Investment Research Hims & Hers stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report American Well Corporation (AMWL) : Free Stock Analysis Report Hims & Hers Health, Inc. (HIMS) : Free Stock Analysis Report LifeMD, Inc. (LFMD) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
